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The KCL028 human embryonic stem cell linewas derived from an embryo donated for research that carried an au-
tosomal dominantmutation affecting one allele of the HTT gene encoding huntingtin (43 trinucleotide repeats; 21
for the normal allele). The ICM was isolated using laser microsurgery and plated on γ-irradiated human foreskin
ﬁbroblasts. Both the derivation and cell line propagation were performed in an animal product-free environment.
Pluripotent state and differentiation potential were conﬁrmed by in vitro and in vivo assays.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Fig. 2. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining (Oct. 4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Actin stress
ﬁbers, visualized with rhodamine-phalloidin (red), are present in both feeders and hES cell colonies, whereas AP activity (green) is detected only in hES cells. Scale bar, 50 μm.
Sex Male 46, XY
Grade Research
Disease status (Fig. 1) Mutation affecting one allele of the HTT gene
encoding huntingtin (~43 CAG repeats; 21 for the
normal allele) associated with Huntington's
disease (Ilic et al., 2015)
Karyotype (aCGH) No imbalance detected.
DNA ﬁngerprint Allele sizes (in bp) of 17 microsatellite markers
speciﬁc for chromosomes 13, 18 and 21 (Jacquet
et al., 2015)
HLA typing HLA-1: 02,03;−B:07,35,−C: 04,07; Bw: 6; DRB1:
01; DQB1: 05
Viability testing Pass
Pluripotent markers
(immunostaining)
(Fig. 2)
NANOG, OCT4, TRA-1-60, TRA-1-81, AP activity
(Jacquet et al., 2015)
Three germ layers
differentiation in vitro
(immunostaining)
(Fig. 3)
Endoderm: AFP (α-fetoprotein); Ectoderm:
TUBB3 (tubulin, β3 class III); Mesoderm: ACTA2
(actin, α2, smooth muscle) (Jacquet et al., 2015)
Three germ layer
differentiation in vivo
(teratomas)
(Fig. 4)
Endoderm: AFP, GATA4. Ectoderm: TUBB3, GFAP
(glial ﬁbrillary acidic protein). Mesoderm: DES
(desmin), Alcian Blue and periodic acid–Schiff
(PAS)-stained cartilage (Jacquet et al., 2015)
Targeted differentiation Cardiomyocytes: TNNT2 (cardiac troponin T)
immunostaining
Sibling lines available KCL027
We generated KCL028 research grade hESC line following protocols,
established previously (Ilic et al., 2012; Stephenson et al., 2012). The ex-
pression of the pluripotencymarkers was tested after freeze/thaw cycle
(Ilic et al., 2012). Differentiation potential into three germ layers was
veriﬁed in vitro (Jacquet et al., 2015) and in vivo (Jacquet et al., 2015).
Materials and methods
Consenting process
We distribute Patient Information Sheet (PIS) and consent form to
the in vitro fertilization (IVF) patients if they opted to donate to research
(continued) embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent were
mailed to them. If in themeantime new versions of PIS/consent are im-
plemented, we do not send these to the patients or ask them to re-sign;
thewhole process is donewith the version thatwas given them initially.
The PIS/consent documents (PGD-V.8) were created on Jul. 01, 2010.
HFEA Code of Practice that was in effect at the time of document crea-
tion: Edition 8 – R.2 (http://www.hfea.gov.uk/2999.html). The donor
couple signed the consent on Jan. 12, 2011. HFEA Code of Practice that
was in effect at the time of donor signature: Edition 8 – R.2. HFEA
Code of Practice Edition 8 – R.2 was in effect: Apr. 07, 2010–Apr. 06,
2011.
Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFF).
Cell culture
ICMplated onmitotically inactivatedHFFwere cultured as described
(Ilic et al., 2012; Stephenson et al., 2012). TE cells were removed
mechanically from outgrowth (Ilic et al., 2007; Ilic et al., 2010). hESC
colonies were expanded and cryopreserved at the third passage.
Viability test
Strawswith the earliest frozen passage (p. 2–3) are thawed and new
colonies are counted three days later. These colonies are then expanded
up to passage 8, atwhich point cellswere part frozen and part subjected
to standard battery of tests (pluripotency markers, in vitro and in vivo
differentiation capability, genetics, sterility, mycoplasma).
Fig. 1.Genetic pedigree tree. The couple undergoing IVF had 16 embryos in this particular cycle. Three embryoswere normal,whereas those that carried themutation inHTTwere donated
for research. We derived hESC lines from two of them.
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Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymatic
activity assay [alkaline phosphatase (AP) assay] and immunostaining as
described (Ilic et al., 2012; Stephenson et al., 2012; Petrova et al., 2014).
Differentiation
Spontaneous differentiation into three germ layers was assessed
in vitro as described (Ilic et al., 2012; Stephenson et al., 2012; Petrova
et al., 2014) and in vivo (Jacquet et al., 2015). Targeted differentiation
in cardiomyocytes followed the protocols described earlier (Jacquet
et al., 2015; Laﬂamme et al., 2007).
Genotyping
DNAwas extracted fromhESC cultures using aChemagenDNAextrac-
tion robot according to the manufacturer's instructions. Ampliﬁcation of
polymorphic microsatellite markers was carried out as described (Ilic
et al., 2012). Allele sizes were recorded to give a unique ﬁngerprint of
each cell line.
Array comparative genomic hybridization (aCGH)
aCGH was performed as described in details (Ilic et al., 2012).
HLA typing
HLA-A, -B and -DRB1 typing was performed with a PCR sequence-
speciﬁc oligonucleotide probe (SSOP; Luminex, Austin, TX, USA) hybridi-
zation protocol at the certiﬁed Clinical Transplantation Laboratory, Guy's
and St Thomas' NHS Foundation Trust and Serco Plc. (GSTS) Pathology
(Guy's Hospital, London, UK) as described (Jacquet et al., 2013).
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